Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00729430 · ClinicalTrials.gov registry record · Phase 3
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
A Phase 3 study of Myocardial Infarction and Death, Sudden, Cardiac, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 358
- Enrollment target
- 1
- Study location
NCT00729430 is a Phase 3 study of Myocardial Infarction and Death, Sudden, Cardiac that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 358 participants, below the 4,676-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00729430, a Phase 3 study of Myocardial Infarction and Death, Sudden, Cardiac, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 358 participants
- Enrollment target
- 1
- Study location
Study Summary
Doctors use magnetic resonance imaging (MRI) to obtain detailed pictures of the inside of the body. This study will evaluate a new MRI technique in people who have recently had a heart attack. Researchers will also examine the effect of fish oil supplementation on heart health in study participants.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Omega-3 Fatty Acids (Fish Oil Supplements)
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital, Shapiro Cardiovascular Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2008-08 |
| Est. Completion | 2014-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00729430
The ClinicalTrials.gov registry entry for NCT00729430 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,676-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (92% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00729430 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00729430 about?
NCT00729430 is a clinical study titled "Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging". Doctors use magnetic resonance imaging (MRI) to obtain detailed pictures of the inside of the body. This study will evaluate a new MRI technique in people who have recently had a heart attack. Researchers will also examine the effect of fish oil supplementation on heart health in study participants.
What is the current status of trial NCT00729430?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 358 participants. The study started on 2008-08. Estimated completion is 2014-07.
What conditions does trial NCT00729430 study?
This clinical trial studies the following conditions: Myocardial Infarction, Death, Sudden, Cardiac.
What interventions are being tested in trial NCT00729430?
The interventions under investigation include: Placebo (DRUG), Omega-3 Fatty Acids (Fish Oil Supplements) (DRUG).
Who is sponsoring clinical trial NCT00729430?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00729430 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
COMPLETED · Phase 3
-
Occluded Artery Trial (OAT)
COMPLETED · Phase 3
-
IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
COMPLETED · Phase 3
-
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
COMPLETED · Phase 3
-
Myocardial Ischemia and Transfusion Pilot
COMPLETED · Phase 3
-
Vitamin Therapy for Prevention of Stroke
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.